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ABSTRACT 
High level of positive affectivity serves as a protective factor against adverse effects of stress 
and low positive affectivity increases vulnerability to mental disorders, i.e. mood disorders 
and drug abuse. In animal models, rat 50-kHz ultrasonic vocalizations index the level of 
positive affect, whereas there are stable, trait-like inter-individual differences in terms of 
vocalization activity. Previously, we have demonstrated that experience of chronic stress can 
suppress amphetamine-induced 50-kHz vocalizations, but only in animals with low levels of 
vocalization activity. In the present study it was tested, whether the chronic stress effect on 
USV activity is preventable with fluoxetine treatment. Male Wistar high (n=32) and low 
(n=30) 50-kHz vocalizing rats were subjected to 43-day chronic variable stress (CVS) 
regimen. On day 17 of the CVS, fluoxetine treatment was started, followed up by the 19-day 
amphetamine test with USV and locomotor data recording on the 1
st
, 10
th
 and 19
th
 day. 
Chronically stressed rats developed cross-sensitization between previous CVS regimen and 
repeated administration of amphetamine in both groups of HC, and also in fluoxetine-
pretreated LC rats. Fluoxetine had a different effect in chronically stressed rats with high and 
low trait of positive affectivity. Fluoxetine pretreatment increased the frequency-modulated 
and trill calls in proportions in repeatedly amphetamine treated LC rats, but not in any other 
group. These findings suggest that fluoxetine treatment modulates the effect of chronic stress 
on the rewarding effects of amphetamine depending on inter-individual differences in positive 
affectivity. 
Keywords: positive affectivity, 50-kHz vocalizations, chronic stress, amphetamine, 
behavioural sensitization 
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Fluoksetiin modereerib amfetamiini vastust kõrge ja madala positiivse 
afektiivsusega kroonilises stressis rottidel 
KOKKUVÕTE 
Madalat positiivset afektiivsust käsitletakse kui haavatavat faktorit patoloogiate, nagu 
meeleolu- ja sõltuvushäirete välja kujunemisel. Loomkatsemudelites mõõdetakse positiivset 
afektiivsust rottide 50-kHz ultrahelihäälitsustega ehk kudinatega. Kudisemisaktiivsuses 
esinevad seadumuslikud erinevused, mille alusel saab rotte jagada palju- (HC) ja 
vähekudisejateks (LC). Varasemalt oleme näidanud, et krooniline stress vähendab 
amfetamiini poolt esile kutsutud kudisemisaktiivsust vähem kudisevatel rottidel. Käesoleva 
väitekirja eesmärgiks on uurida, kas kroonilise stressi efekt kudisemisaktiivsusele on 
ennetatav fluoksetiiniga. Isased Wistar liini palju- ja vähekudisevad rotid läbisid 43-päevase 
kestusega kroonilise muutliku  stressirežiimi (CVS), mille 17. päeval alustati fluoksetiini 
manustamist. Pärast stressirežiimi manustati pooltele HC ja LC rottidele amfetamiini (1 
mg/kg; IP), koos kudisemis- ja liikumisaktiivsuse andmete salvestamisega 1., 10. ja 19. 
päeval. Kroonilises stressis rottidel kujunes amfetamiini korduvmanustamisel välja ristuv 
sensitisatsioon mõlemas HC grupis, ühtlasi ka fluoksetiini kuuri läbinud LC rottidel. 
Fluoksetiin moduleeris kroonilise stressi mõju amfetamiini poolt esile kutsutud häälitsustele 
HC ja LC gruppides erinevalt. Fluoksetiinikuuri läbinud kroonilises stressis rottidel kasvas 
amfetamiini korduvmanustamisel eksklusiivselt sagedusmuutlike ja trillielementidega 
häälitsuste protsentuaalne osakaal. Eelnevalt kirjeldatud tulemused näitavad, et fluoksetiin 
moduleerib kroonilise stressi mõju amfetamiini korduvamanustamisel kogetavatele 
tasustavatele efektidele HC ja LC rottidel erinevalt. 
Märksõnad: positiivne afektiivsus, 50-kHz ultrahelihäälitsused, krooniline stress, 
amfetamiin, käitumuslik sensitisatsioon 
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INTRODUCTION 
Individual variability in vulnerability to stress related psychiatric disorders is usually 
understood in framework of diathesis-stress model, which sees vulnerability (the diathesis) 
and precipitation (the stress) as separable components in the process leading to pathological 
condition (Willner, Scheel-Krüger, and Belzung 2013). Vulnerability to stress is determined 
by diverse set of interacting factors of genetic, behavioural and environmental nature 
(Armario & Nadal 2013). The diathesis-stress concept has often been applied to depression 
studies, in which several risk factors for developing the pathology have been identified. 
Large body of research has described neuroticism as one of the key risk factor for several 
psychopathologies, i.e. in affective disorders (Roelofs, Huibers, Peeters, Arntz 2008), and in 
schizophrenia (Blanchard, Mueser, Bellack 1998). Past research has however somewhat less 
emphasized the role of protective factors, which can convey resilience to stress and prevent 
the development of pathologies. Some recent findings have suggested that high level of 
positive affectivity serves as a protective factor (Werner-Seidler, Banks, Dunn & Moulds 
2013; Nutt, Demyttenaere, Janka, Aarre, Bourin et al 2007), whereas low positive affectivity 
increases vulnerability (Mällo, Matrov, Kõiv, and Harro 2009; Clark & Watson 1991; Horan 
& Blanchard 2003). 
Individual differences in rat 50-kHz ultrasonic vocalizations as an indicator of positive 
affectivity 
Regarding behavioural readouts in potential animal models of resilience, 50-kHz ultrasonic 
vocalizations (USV-s; often referred as “chirps”) most reliably index the level of positive 
affect in the rat (Knutson, Burgdorf & Panksepp 2002). Fifty-kHz vocalizations are naturally 
emitted in response to various positive stimuli; for example food (Brenes & Schwarting 
2015), mating (Knutson et al 2002), natural or imitated rough-and-tumble play (Mällo et al 
2007; Knutson, Burgdorf & Panksepp 1998), and in response to pharmacological activation of 
mesolimbic brain reward circuitry (Burgdorf, Knutson, Panksepp 2001; Browning, Browning, 
Maxwell, Dong, Jansen 2011; Simola & Morelli 2015). The presence of trait-like inter-
individual differences in 50-kHz vocalization activity has been proposed on the grounds that 
rats can be selectively bred for high or low levels of USV activity (Burgdorf, Panksepp, 
Brudzynski, Kroes, Moskal 2005; Webber et al 2012). Such stable differences are also 
persistently expressed in response to experimentally imitated rough-and-tumble play (Mällo et 
al 2007) and in response to drug treatment (Taracha, Hamed, Krzaścik, Lehner, Skórzewska 
2012). Furthermore, the rats with lower 50-kHz vocalization activity show elevated levels of 
anxiety in several tests (Burgdorf, Panksepp, Moskal 2011). Thus, low positive affectivity 
phenotype in rats appears to have potential in obtaining new information about development 
of psychopathologies. 
It is now well-established that USV-s serve as social signals for rodents in emotionally 
valenced conditions. Vocalizations with the 50-kHz frequency component vary in their 
characteristics and are generally divided into two broader categories. Firstly, the ones being in 
near constant frequency, named flat calls, and secondly the calls, which include frequency 
modulations, often referred as “FM calls” (Brudzynski 2015). Both subtypes of USV-s have 
been associated with positive affective states; however, there is a difference in the context 
these are emitted. Flat calls have been proposed to have a social-coordinating function, for 
example in a situation of aggressive encounter between two male rodents (Wöhr, Houx, 
Schwarting, and Spruijt 2008). Calls with frequency modulation have been described in 
studies with rewards and psychostimulant-induced euphoria (Mahler et al 2013; Ahrens, Ma, 
Maier, Duvauchelle, and Schallert 2009). Moreover calls with frequency modulation can be 
divided by their acoustic parameters into 13 different categories (detailed description of the 
subtypes can be found in Wright, Gourdon, and Clarke 2010). 
According to Wright et al (2010), the proportions of the calls seem to be affected by social 
context. The authors measured USV activity among rats in pairs and singly, resulting in 
significantly different call profiles between experimental conditions. Pair-tested rats had 
significantly higher proportion of trill calls and lower proportion of flat calls compared to 
their respective singly-tested group. These differences remained even when rats were 
administered amphetamine. Unfortunately no further work to my knowledge has done in 
studying the 50-kHz vocalization response, while considering proportions of different call 
subtypes. Larger body of research with USV-s focuses in measuring number of calls emitted, 
and testing the rats singly, not in pair, although the importance of the social context should be 
taken into account, especially in research on flat and frequency-modulated calls with trill 
elements. 
The frequency-modulated calls with trill elements, or simply “trill calls”, have gained more 
focus in pharmacological studies (Ahrens et al 2009; Simola & Morelli 2015). The widely 
acknowledged hypothesis suggests that trill calls have an association with psychostimulant-
induced hedonic and euphoric effects. Inquiries about their neural substrates have established 
an association between trill calls and midbrain dopamine pathways, often referred as brain 
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reward system. Wright and colleagues (2013) have reported that blocking dopamine D1 and 
D2 receptors attenuates the number of trill calls elicited by rats, with the effect being strongest 
when both D1 and D2 receptors are blocked simultaneously. Furthermore, Ringel et al (2013) 
have shown that simultaneous blockage of D1 and D2 receptors leads to reduction in mean 
complexity and bandwidth in 50-kHz ultrasonic vocalizations, while also reducing the overall 
number of USV-s with frequency modulation component. Thus, the proportions of different 
subtypes of calls should be responsive to manipulation of midbrain dopamine levels, 
including amphetamine administration. 
Studies with drug sensitization and repeated exposure to amphetamine 
Previous work combining measurement of rodents’ ultrasonic vocalizations has mostly been 
carried out in context of studying biological basis of drug addiction. In those studies the 
sensitization effect has been emphasized (Cador, Bjijou, Cailhol, Stinus 1999). Sensitization 
describes an effect, where repeated exposure to a certain stimulus enhances behavioural and 
physiological response to the same stimulus at subsequent time points (Steketee & Kalivas 
2011). For example, if rats are repeatedly administered psychoactive drugs, it would result in 
significantly increased number of ultrasonic vocalization activity in contrast with the 
respective control group. Several studies have shown that repeatedly administering low doses 
of amphetamine induces behavioural sensitization in rodents, resulting in hyperlocomotion 
and increased numbers of USV-s emitted (Mu et al 2009; Vanderschuren et al 2001). 
Previous research has revealed that some subtypes of USV-s are more susceptible to 
sensitization than others. Repeated amphetamine treatment seems to preferentially lead to 
sensitization of USV-s with frequency modulation component (Ahrens et al 2009; Wright et 
al 2013). Ahrens et al (2009) also showed concurrency of sensitization of calls with frequency 
modulation and locomotor activity. Also other dopaminergic drugs, such as cocaine seem to 
be capable of inducing sensitization of FM calls if administrated repeatedly (Maier, Abdalla, 
Ahrens, Schallert, and Duvauchelle 2012). It is important to note that at least one previous 
experiment hints at the possibility of presence of intra-individual differences in sensitization 
of 50-kHz USV-s in response to repeated amphetamine treatment. Namely, Taracha and 
colleagues (2012) found that sensitization of USV-s could only be described in some animals, 
whereas others showed no significant elevation in vocalization activity in response to repeated 
treatment with amphetamine. Thus, it is possible that the effect of repeated amphetamine 
treatment could be different in rats with high vs. low positive affectivity, if one rat phenotype 
would be more susceptible to sensitization than the other. 
Previous work on chronic stress and antidepressants 
Various chronic stress models have been developed to study the stress response and human 
depression in animals. Katz and colleagues (1982) introduced the chronic variable stress 
regimen, that later was further developed to chronic mild stress by Willner and colleagues 
(1987). There are methodological differences between these models, but the central idea is the 
same; animals are intermittedly presented with variety of uncontrollable stressors, which 
should result in subject’s depression-like state, indicated by slower weight gain, decreased 
sugar preference and higher body temperature (Harro, Tõnissaar, Eller, Kask, Oreland 2001; 
Mällo et al 2009). These symptoms can be reversed with antidepressant treatment (Tõnissaar 
et al 2008).  
Previous work has shown that rats show inhibited levels of USV activity in response to 
chronic variable stress regimen, while the effect is larger among male animals with lower 
levels of baseline vocalizing (Mällo et al 2009). Similar results were also described in 
Raudkivi et al (2012) study, and also found with the restraint stress model (Popik, 
Potasiewicz, Pluta, Zieniewicz 2012). Thus, animals with lower levels of USV activity seem 
to be more susceptible to stress regimen. Furthermore, in our most recent study we replicated 
that effect and found out that chronic stress can suppress amphetamine-induced fifty-kHz 
vocalizations, but that effect could only be described among animals with low levels of 
vocalization acitvity (Kõiv et al 2016). The attenuated number of calls was seen in all 
subtypes of calls we differentiated, that being trills and frequency-modulated calls, as well as 
flat and short calls. These results suggest, that chronic stress causes blunted hedonic response 
among rats with low levels of vocalizing.  
Since the chronic stress effect can be reversed with antidepressants, it is possible that stress 
induced reduction of USV-s in repeated amphetamine treatment setting among rats with low 
level of positive affectivity is reversable by antidepressant treatment. To my knowledge, no 
previous work has been published, which studies the effect of antidepressant treatment on 50-
kHz ultrasonic vocalizations in chronically stressed rats. In fact, there is only one study, 
published by Boulay and colleagues (2013), which describes the fluoxetine to have no effect 
on rat USV-s. The present experiment further studies the effect of fluoxetine on rat 50-kHz 
ultrasonic vocalizations, providing some new insights on one of the most used and well-
known SSRI’s effect on behaviour and emotion regulation in chronic stress setting. 
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Aims of this study 
The aim of this thesis is to test the effect of fluoxetine on amphetamine-induced rat 50-kHz 
ultrasonic vocalizations in chronically stressed animals with high vs. low trait of positive 
affectivity. The present study addresses the following research questions: 
 Does the antidepressant treatment affect the chronic stress effect on USV response to 
repeated amphetamine treatment? 
 How the latter is reflected in different subtypes of USV-s? 
 How does the USV response differentiate in chronically stressed rats with inter-
individual differences in positive affectivity? 
This study is part of a larger experiment and not all data will be reported here. The author of 
this thesis contributed to all assignments and parts of the experiment, mostly during chronic 
stress regimen, fluoxetine and amphetamine treatment and behavioural tests. Nevertheless this 
experiment was managed in full cooperation of all contributors and could not have been 
successful otherwise. 
EXPERIMENTAL PROCEDURES 
 
Animals  
Male Wistar rat pups (n=62) were weaned at the age of three weeks. Parents were provided by 
Harlan Laboratories (the Netherlands) and the animals were bred on location. Juvenile rats 
were single-housed in standard transparent polypropylene cages with wood-chip bedding in a 
temperature controlled room (20–22°C) under 12:12 light/dark cycle, light-cycle starting at 
08:00 hours. Rats had ad libitum access to tap water and food (diet R70, Lactamin AB, 
Sweden), except during testing. After the tickling sessions, animals were group-housed by 
four, each cage consisting of equivalently HC and LC animals. All behavioural experiments 
were performed during light-period. The experiments were in accordance with EU legislation 
(directive 2010/63/EU) and the experimental protocol was approved by the Animal 
Experimentation Committee at the Estonian Ministry of Agriculture. 
General procedure 
Table 1. Timetable of the experiment. 
Procedure Age of animals Notes 
Weaning from mother Week 3  
Tickling by experimenter Weeks 4-6 (period of 14 days)  
Intermediate group housing Weeks 7-12 Time period for USV counting 
Re-grouping the housing of 
animals 
Week 13  
Pre-CVS behavioural testing Week 14 Stress-induced hyperthermia; sucrose preference 
Pre-fluoxetine CVS regimen 
Weeks 14-17 (period of 16 
days) 
 
Fluoxetine w/ CVS regimen Week 17-20 (period of 27 days) Fluoxetine at dose of 10 mg/kg 
Behavioural testing Week 21 (period of 5 days) 
In following order: stress-induced hyperthermia; 0-maze; T-maze; 
re-tickling and NSF 
Habituation with amphetamine 
experiment cage 
End of week 21 (period of 4 
days) 
USV recording on day 2 of habituation (data not reported). 
Amphetamine treatment 
Weeks 22-23 (period of 10 
days) 
Amphetamine treatment at dose of 1 mg/kg for half of the animals. 
USV and locomotor activity recording on 1st and 10th day. 
Sensitization 
testing/Amphetamine challenge 
Week 24 (9 days after last 
chronic amphetamine dose) 
19th day of amphetamine test. Amphetamine treatment at dose of 1 
mg/kg for all animals. USV and locomotor activity recording. 
Sacrifice of animals 
Week 30 (5 days after 
challenge) 
 
Tickling sessions started one day after single-housing. Sessions lasted for 14 days, including 
one 2-min tickling session per day. Juvenile rats were divided between HC and LC groups by 
the median split of total chirping activity across three measurement days (days 12-14 of 
tickling procedure). At the age of four months, 32 animals were assigned to chronic variable 
stress regimen (CVS) with duration of 43 days, consisting of one short-lasting stressor during 
daytime and a whole night lasting stressor in the dark phase. Subsequently half of the CVS 
rats (n=16) were administered with fluoxetine for 27 days. Antidepressant treatment started 
on the 17
th
 day of the CVS regimen and ended with CVS regimen (day 43 of CVS regimen). 
Immediately after CVS, behavioural testing was carried out during the next 5 days (data not 
reported). 
The day after behavioural testing, animals were habituated with the experiment cage for four 
days for the amphetamine treatment procedure, which was carried out on the following 10 
days. Nine days after the end of repeated amphetamine treatment all animals received a 1 
mg/kg injection of amphetamine. Ultrasonic vocalizations and locomotor activity were 
recorded on day 1, 10 and 19. The rats were sacrificed by decapitation five days after 
amphetamine challenge.  
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Tickling 
Tickling of juvenile animals carried out by an experimenter, imitates natural rough-and-
tumble play, a characteristic behaviour in young rats. The animal was given 15 s to habituate 
with the new cage (30×15×13 cm), followed by 15 s of tickling by experimenter. The tickling 
sessions consisted of four manual stimulation sessions during 2 min. In short, the “tickling” 
session that each animal received consisted of stimulating the rat with one hand by the 
experimenter, that included rapid finger movements on the back of the neck, turning the 
animal on the back and letting it “wrestle” with the experimenter’s hand with vigorous 
alternating finger movements administered on the animals’ ventral surface, followed by 
release after 1–2 s of stimulation. (Mällo et al 2007; Burgdorf and Panksepp 2001; Panksepp 
and Burgdorf 2000) 
In the 2-min sessions chirping was recorded with an ultrasound microphone (Avisoft Ultra 
Sound Gate 116-200, Avisoft Bioacoustics, Berlin, Germany), located 20 cm from the cage 
floor. USV-s were recorded with a sampling rate of 300 kHz in 16 bit format and later 
manually scored with the Avisoft SASLab Pro (Avisoft Bioacoustics, Berlin, Germany) 
software by creating spectrograms using fast Fourier transformation (1024 FFT length, 75% 
frame, Hamming window, and 75% time window overlap). The average number of 50-kHz 
calls during the tickling periods in tickling days 12-14 was 227±3 in HC group and 135±8 in 
LC rats. 
Recording apparatus and the amphetamine administration 
The experiment was carried out in the colony room, with the experiment cage (floor - 1815 
cm
2
) isolated from the home cages with a screen in the most far corner of the room. The 
experiment cage was identical to their home cage with wood-chip bedding and wire-mesh lid. 
The ultrasound microphone was located approximately 30 cm above the cage floor.  
Rats were weighed every day before amphetamine administration. After four days of 
habituation with the experiment cage, half of the animals (n=31) were administered 
amphetamine 1 mg/kg, while the other half (n=31) were administered with equivalent amount 
of saline IP. Subjects were instantaneously placed in the recording cage for 15 min, and the 
ultrasonic vocalizations with locomotor activity data were collected on day 1, 10 and 19 
(otherwise the procedure was identical except data was not recorded). On the day 19, all 
animals were administered a single dose of amphetamine IP (1 mg/kg). 
Analysis of USVs and locomotor activity 
Seven time-bins were chosen out of the 15-min recorded data, based on their correlation to 
overall chirping scores during 15 min. Hence the minutes 1; 3; 5; 7; 9; 11 and 13 from audio 
recordings were scored. The vocalizations were manually scored from spectrogram by 
experimenter blind to experimental conditions. Categorization was made according to the 
method of Wright et al. (2010), and further grouped together into four categories: 1) trill calls 
(which included trill, flat-trill combination, trill with jumps); 2) frequency-modulated calls 
(consisting of complex, upward ramp, downward ramp, split, step up, step down, multi-step, 
inverted U, composite type of calls); 3) flat calls; 4) short calls. 
Locomotor activity was measured by counting rearings (rat on two hind paws, at least at an 
angle of 45-degrees) and line crossings (all four paws were over the line), scored from 15-min 
digital video recordings, and scored in three 5-min bins. In order to estimate the line 
crossings, experimental cage was divided into six equal-sized squares. 
Chronic variable stress 
The chronic variable stress regimen lasted for 6 weeks, consisting of various stressors 
interchangeably used during the week. The CVS regimen included one short stressor during 
daytime and one long lasting stressor during nighttime. Control rats were left undisturbed in 
the colony room; all the stressors were presented in separate rooms. The short stressors 
included: 1) rats were exposed to cold temperature for 1 h; 2) placing the animal under strong 
illumination (900 lx) on a round 10 cm diameter platform, which was located 75 cm above 
ground for 30 min; 3) tail-pinch with a clothespin near base of the tail for 5 min; 4) restricted 
mobility in an tight space (25x9 cm) lasting 2 h; 5) grabbing the rat with a thick glove, 
immobilizing it for 5 min. Night-time long stressors were: 1) stroboscopic light (10-50 Hz; 12 
h); 2) lights on during night-time, lasting 12 h; 3) tilted cage at 45-degree angle for 12 h, 4) 
loud white noise in 10-minute time-bins, followed by 1 h of silence in 6 repeated cycles; 5) 
removing the home cage bedding and replacing it with 1 cm cold water for 12 h. 
Measurement of weight gain 
Weight gain was used as an indicator to test the effectiveness of chronic variable stress 
regimen. It was calculated for 5 successive time points by subtracting the pre-CVS 
bodyweight from bodyweight of respective measurement. The first measurement corresponds 
to the 16-day period of CVS before starting fluoxetine administration. Measurements 2-4 
correspond to simultaneous CVS and fluoxetine administration (in total 27 days). Data used 
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for analysis were collected on the 16
th
 (Measurement 1), 23
rd
 (Measurement 2); 30
th
 
(Measurement 3), 37
th
 (Measurement 4), 43
rd
 (Measurement 5) day of CVS regimen. 
Drugs 
Fluoxetine hydrochloride (Tokyo Chemical Industries, Japan) was administered in sterile 
saline solution 10 mg/kg IP after daily CVS procedures in home cage. Fluoxetine treatment 
began on the first day of week 3 of CVS regimen and lasted for 27 days (ended 
simultaneously with CVS regimen). 
D-Amphetamine sulphate (Tocris Bioscience, Bristol, UK) was dissolved in sterile 0.9% 
saline and administered in the dose of 1 mg/kg (as for salt) in a volume of 1 ml/kg IP before 
placing the animal to the experiment cage.   
Statistical analysis 
Statview (SAS Institute Inc., USA) and Statistica (StatSoft Inc., Tulsa, USA) were used for 
factorial and repeated-measures analysis of variance, with independent factors being HC vs 
LC, Stress (vs control), Fluoxetine (vs vehicle), Amphetamine (vs saline) and the dependent 
factors being total amount of USV-s per recording and separately all the subcategories (trill, 
flat, frequency-modulated and short calls) of USV-s. Locomotor activity on day 19 was 
analyzed with four-factor ANOVA with the same categorical variables as for analysis of 
USV-s. Two-tailed Pearson correlation coefficient was calculated in order to describe the 
associations between USV and locomotor activity. Recording day was used as a repeated 
measures factor where appropriate. Fisher’s PLSD was used for post-hoc testing. 
RESULTS 
Weight gain 
The measure of weight gain was used to assess the effectiveness of CVS regimen and 
fluoxetine treatment. Weight gain was calculated for 5 successive time points by subtracting 
the pre-CVS bodyweight from bodyweight of respective measurement. Figure 1 depicts the 
cumulative weight across 5 measurements between groups of stressed, fluoxetine-treated, and 
their respective control animals. In detail, animals gained weight over the 43 day period 
[F(4,216)=45.97; p<.0001], whereas CVS and fluoxetine decreased the weight gain 
[Measurement × Stress - F(4,216)=24.82; p<.0001 and Measurement × Fluoxetine – 
F(4,216)=130.28; p<.0001, respectively]. In terms of HC/LC affiliation, there were no 
significant differences, although the slowest weight gain in both groups resulted from 
interaction of CVS and fluoxetine administration [Measurement × Stress × Fluoxetine – 
F(4,216)=2,59; p<.05]. Repeated measures ANOVA displayed within measurement main 
effects with stress [F(1,54)=61.41; p<.0001] and fluoxetine [F(1,54)=78.77; p<.0001]. 
 
Figure 1. Weight gain during chronic variable stress regimen and fluoxetine administration. Data reported as 
mean scores + SEM. #, ##, ### - p<.05, .01 vs control, respectively; +, ++, +++ - p<.05, .01, .001 vs vehicle, 
respectively. Measurements 2-4 correspond to simultaneous CVS and fluoxetine administration (in total 27 
days). Data used for analysis were collected on the 16
th
 (Measurement 1), 23
rd
 (Measurement 2); 30
th
 
(Measurement 3), 37
th
 (Measurement 4), 43
rd
 (Measurement 5) day of CVS regimen. 
 
Overall number of ultrasonic vocalizations during amphetamine administration 
Four-factor repeated measures ANOVA showed that the overall number of 50-kHz ultrasonic 
vocalizations was significantly different on testing days 1, 10 and 19 [F(2,92)=117.3; 
p<.0001], depending on CVS regimen and amphetamine treatment [Day × Stress - 
F(2,92)=3.6; p<.05 and Day × Amphetamine - F(2,92)=3.8; p<.05, respectively]. Moreover 
these variables presented an interaction effect [Day × Stress × Amphetamine - F(2,92)=5.5; 
p<.005], which tended to have differential effect on vocalization activity across testing days. 
As seen on Figure 2, the amphetamine treatment increased vocalization activity on day 1, 
whereas CVS regimen had no significant effect on number of USV-s. However on the 10
th
 
and 19
th
 day, stress potentiated the effect of repeated amphetamine on overall number of 
USV-s. Across three testing times ANOVA revealed main effects on HC/LC affiliation 
[F(1,46)=8.7; p<.01] and amphetamine treatment [F(1,46)=17.5; p<.0001]. Generally HC 
groups emitted higher number of vocalizations in response to amphetamine than LC rats 
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[HC/LC × Amphetamine - F(1,46)=4.9; p<.05], and chronic stress potentiated the 
amphetamine response [Stress × Amphetamine - F(1,46)=8.1; p<.01]. 
Figure 2. Mean scores of 50-kHz ultrasonic vocalizations scored from 7 selected time-bins on day 1, 10 and 19 
(data expressed as mean + SEM). On day 19 all animals (n=62) were injected with amphetamine (1 mg/kg, IP) to 
examine the sensitization effect *, **, *** - p<.05, .01, .001 vs day 1, respectively; #, ##, ### - p<.05, .01 stress 
vs control, respectively; +, ++, +++ - p<.05, .01, .001 vs vehicle, respectively; &, &&, &&& - p<.05, .01, .001 
vs saline, respectively; ¤, ¤¤, ¤¤¤ - p<.05, .01, .001 vs LC, respectively. 
On day 1, amphetamine increased USV numbers among all HC animals, although this effect 
was significant only among non-stressed fluoxetine-treated HC rats and stressed vehicle-
treated HC group. Interestingly, there were no differences between LC rats’ vocalization 
activity, except among stressed animals, which had been treated with fluoxetine. There was a 
significant amphetamine effect in non-stressed fluoxetine HC animals on day 1 (p<.05), but 
not on day 10 and 19. In fact, there seemed to be reduction in number of USV-s on day 10, 
compared with testing day 1 (p<.05), with significantly smaller number of USV-s emitted 
than their respective stress group (p<.01). On day 10, amphetamine had a USV-increasing 
effect among HC-stress groups (p<.001), and in fluoxetine-treated LC-stress group (p<.05).  
On day 19, a single dose of amphetamine elicited a significant increase in number of USV-s 
in comparison to day 1 across all groups (p<.05). Exceptions were non-stressed fluoxetine HC 
animals, which had been previously repeatedly treated with amphetamine, and LC stressed 
fluoxetine group, which were previously saline-treated. CVS regimen had an USV-inhibiting 
effect in LC-stress fluoxetine group (p<.05), despite the significant increase in USV numbers 
due to a single dose of amphetamine (p<.05).  
Repeated treatment with amphetamine increased 50-kHz vocalization response among 
stressed HC animals (p<.05) and in fluoxetine-treated LC-stress group (p<.05). On day 19 
these groups emitted significantly higher number of ultrasonic vocalizations, in contrast to 
their scores on day 1 and their respective saline-treated groups. Thus, emergence of 
sensitization effect can be concluded in aforementioned groups. 
Trill calls during amphetamine administration 
Number of trill calls differed across testing days [F(2,92)=39,7; p<.0001], with only 
significant main effect being amphetamine treatment [F(1,46)=4.8; p<.05]. Interestingly, a 
single dose of amphetamine increased the number of trill calls on day 19 across several 
groups, while there were no significant differences between groups on days 1 and 10. (Figure 
3) 
 
Figure 3. Mean scores of trill vocalizations scored from 7 selected time-bins on day 1, 10 and 19 (data expressed 
as mean + SEM). On day 19 all animals (n=62) were injected with amphetamine (1 mg/kg, IP) to examine the 
sensitization effect. *, **, *** - p<.05, .01, .001 vs day 1, respectively; #, ##, ### - p<.05, .01 vs control, 
respectively; +, ++, +++ - p<.05, .01, .001 vs vehicle, respectively; &, &&, &&& - p<.05, .01, .001 vs saline, 
respectively; ¤, ¤¤, ¤¤¤ - p<.05, .01, .001 vs LC, respectively. 
Interestingly, fluoxetine elicited increase in numbers of trill calls on day 19 among LC non-
stressed animals, who had previously received amphetamine treatment (p<.05). In addition 
there was a prevalent sensitization effect among vehicle-treated stressed HC animals, 
compared to their number of trill calls on day 1 and their respective saline-treatment group 
(both - p<.001). However the latter effect emerged due to small group size, since one animal 
made 416 trill calls on day 19, while the others in this group had a mean number of 63 calls. 
Excluding this rat from analysis, there was no significant increase in mean number of trill 
calls in this group, contrasting to their number of trill calls emitted on day 1 and respective 
saline-treated group on day 19 (data not reported on Figure 3). 
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Repeated treatment with amphetamine exclusively evoked sensitization among fluoxetine-
treated stressed LC group, which showed increased 50-kHz vocalization activity on day 19, in 
contrast to their USV activity on day 1 and their respective saline-treated group (both - p<.01) 
The proportion of trill calls in number of overall USV-s differed across testing days 
[F(2,92)=54; p<.0001], depending on interaction between CVS regimen and fluoxetine 
treatment (Day × Stress × Fluoxetine) [F(2,92)=4.6; p<.01]. (Table 2) 
Table 2. Trill call percentage from the overall number of USV-s elicited on day 1, 10 and 19. *, **, *** - p<.05, 
.01, .001 vs day 1, respectively; #, ##, ### - p<.05, .01 vs control, respectively; +, ++, +++ - p<.05, .01, .001 vs 
vehicle, respectively; &, &&, &&& - p<.05, .01, .001 vs saline, respectively. 
HC/LC CVS regimen FLUOX/SAL AMPH/SAL GROUP SIZE DAY 1 DAY 10 DAY 19 
HC ctrl veh sal 4 2.6%±1.1% 2.2%±1.3% 6%±1.5% 
HC ctrl veh amph 4 1.9%±1.2% 0.8%±0.5% 3.7%±2.1% 
HC ctrl fluox sal 4 0.3%±0.3% 1.2%±0.5% 6.4%±2.3%*** 
HC ctrl fluox amph 4 2.9%±1.3% 0.7%±0.7% 10.6%±5.7%***++ 
HC stress veh sal 4 0.4%±0.4% 0.7%±0.7% 6.9%±3.6%** 
HC stress veh amph 4 2.8%±1.1% 2.1%±1.1% 12.7%±6.6%***&### 
HC stress fluox sal 4 0.7%±0.4% 0.5%±0.5% 4.4%±1.5% 
HC stress fluox amph 4 0.8%±0.3% 1.8%±0.9% 5.3%±1.5%++ 
LC ctrl veh sal 4 1.6%±0.3% 0.9%±0.3% 5.3%±3.2% 
LC ctrl veh amph 4 1%±0.8% 0.3%±0.3% 3.4%±3.4% 
LC ctrl fluox sal 4 0.4%±0.2% 0.3%±0.3% 4.3%±1.5%+ 
LC ctrl fluox amph 4 2.2%±1.8% 0.5%±0.3% 10%±2.9%***&+ 
LC stress veh sal 3 0.6%±0.6% 0%±0% 5.6%±2.7% 
LC stress veh amph 3 2.7%±1.1% 2%±0.3% 7%±0.7% 
LC stress fluox sal 4 0.4%±0.4% 0.7%±0.7% 3.4%±1.7% 
LC stress fluox amph 4 1.1%±0.3% 2.5%±1.5% 8%±2%** 
Fluoxetine treatment increased trill call proportions in HC and LC non-stressed rats, who 
received repeated treatment with amphetamine, in contrast to their respective vehicle-treated 
groups (p<.05). On the other hand, the antidepressant caused lower trill call rate in stressed 
HC group, who had been repeatedly administered amphetamine, compared to the respective 
vehicle-treated group on day 19 (p<.05). 
On day 19, there were no sensitization in trill call proportions among repeatedly 
amphetamine-treated groups, but the former had a tendency to increase the trill call 
percentage in several HC groups (p<.01). Significant increase in trill call proportions was also 
apparent in fluoxetine-treated LC groups, which had been repeatedly administered 
amphetamine (p<.05).  
 Frequency-modulated calls during amphetamine administration 
Number of frequency-modulated calls differed across testing days [F(2,92)=83; p<.0001], 
depending on CVS regimen [Day × Stress - F(2,92)=6.7; p<.01], amphetamine treatment 
[Day × Amphetamine - F(2,92)=4.3; p<.01] and their interaction effect [Day × Stress × 
Amphetamine - F(2,92)=6.1; p<.01] (Figure 4). Amphetamine treatment [F(1,46)=6.5; p<.01], 
as well as an interaction with CVS regimen [Stress × Amphetamine - F(1,46)=11.3; p<.001] 
had a main effect on number of FM-calls emitted. The amphetamine and chronic stress effect 
on 50-kHz vocalization activity resulted in similar differences in FM-call numbers as they did 
with overall number of vocalizations. 
Figure 4. Mean scores of frequency-modulated vocalizations scored from 7 selected time-bins on day 1, 10 and 
19 (data expressed as mean + SEM). On day 19 all animals (n=62) were injected with amphetamine (1 mg/kg, 
IP) to examine the sensitization effect. *, **, *** - p<.05, .01, .001 vs day 1, respectively; #, ##, ### - p<.05, .01 
vs control, respectively; +, ++, +++ - p<.05, .01, .001 vs vehicle, respectively; &, &&, &&& - p<.05, .01, .001 
vs saline, respectively; ¤, ¤¤, ¤¤¤ - p<.05, .01, .001 vs LC, respectively. 
According to Fisher’s LSD, there were no between-group differences on day 1. However 
there was a non-significant tendency for increased number of vocalizations among all HC 
rats, and fluoxetine-treated LC-stress group. On day 10, stressed HC and fluoxetine-treated 
LC-stress animals showed an increased vocalization activity in response to repeated 
amphetamine treatment, in contrast to their respective saline-treated groups (p<.05). 
Furthermore, the CVS regimen potentiated amphetamine response among fluoxetine-treated 
HC-stress rats on day 10, since their number of USV-s emitted was significantly higher than 
respective non-stress group. In fact, there was a significant reduction in vocalization activity 
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in fluoxetine-treated HC non-stressed group, compared to their mean score of USV-s on day 1 
(p<.05). 
On day 19, CVS regimen reduced the number of FM calls in HC-stress vehicle group (p<.05) 
and among fluoxetine-treated LC-stress animals (p<.01), who had been previously treated 
with saline. It seemed that fluoxetine-treated LC-stress group had a slightly lower FM call 
count than their respective vehicle group, but that effect did not reach statistical significance. 
Repeated treatment with amphetamine elicited sensitization of frequency-modulated calls in 
fluoxetine-treated HC- and LC-stress groups, since the number of FM calls had increased 
compared to testing day 1 (p<.001 and p<.01 respectively), while their respective saline-
treated groups had significantly lower FM call count on day 19 (both – p<.01). Furthermore, 
fluoxetine treatment increased the number of FM calls in LC group, in contrast with vehicle-
treated animals on day 19 (p<.05). Interestingly, the FM call rate in fluoxetine-treated HC-
stress group was significantly higher than their respective non-stress group on day 10 (p<.01), 
since the non-stress animals had a reduced number of FM calls compared to day 1 (p<.05). 
The proportion of FM calls differed across testing days [F(2,92)=14.5; p<.0001], depending 
on the interaction of CVS regimen, fluoxetine treatment and amphetamine administration 
(Day × Stress × Fluoxetine × Amphetamine – F(2,92)=3.3; p<.05) (Table 3). Amphetamine 
treatment had a main effect on the proportion of FM calls [F(1,46)=4.7; p<.05] and 
interactions with CVS regimen and fluoxetine [Amphetamine × Stress - F(1,46)=3.9 and 
Amphetamine × Fluoxetine - F(1,46)=5.1, respectively; both – p<.05). 
Table 3. Frequency-modulated call percentage from the overall number of USV-s elicited on day 1, 10 and 19. 
*, **, *** - p<.05, .01, .001 vs day 1, respectively; #, ##, ### - p<.05, .01 vs control, respectively; +, ++, +++ - 
p<.05, .01, .001 vs vehicle, respectively; &, &&, &&& - p<.05, .01, .001 vs saline, respectively; ¤, ¤¤, ¤¤¤ - 
p<.05, .01, .001 vs LC, respectively.  
HC/LC CVS regimen FLUOX/SAL AMPH/SAL GROUP SIZE DAY 1 DAY 10 DAY 19 
HC ctrl veh sal 4 48.8%±3.6% 52.9%±6.3% 55.5%±2.6%* 
HC ctrl veh amph 4 22.5%±8.5%&& 28.2%±7.7%& 35.7%±10.2% 
HC ctrl fluox sal 4 25.6%±15.2%+ 41.6%±14%* 56.2%±5.2%*** 
HC ctrl fluox amph 4 39.2%±4.9% 27.5%±5.5%& 35.6%±2.1% 
HC stress veh sal 4 34.3%±4.1% 49.9%±3.1% 49%±4.3% 
HC stress veh amph 4 36.7%±5.4% 47.7%±6.7%¤ 42.6%±8.8% 
HC stress fluox sal 4 45.3%±8.9% 38.7%±5.7% 41%±3.2% 
HC stress fluox amph 4 34.6%±5.9% 39.8%±9.8% 46.2%±3.2% 
LC ctrl veh sal 4 35.9%±3.7% 51.5%±4%* 51.2%±3.2%* 
LC ctrl veh amph 4 22%±5.9% 27.5%±6.8%& 42.9%±6.1%** 
LC ctrl fluox sal 4 28%±13.2% 46.1%±6.4%* 49.5%±7.6%** 
LC ctrl fluox amph 4 39.9%±11.1% 31%±3.5% 48%±3.1% 
LC stress veh sal 3 32.5%±4.2% 34.8%±15.1% 31.9%±7.9% 
LC stress veh amph 3 20.7%±3.3% 25.4%±0.8% 23.3%±1.6% 
LC stress fluox sal 4 28.8%±11.7% 39.2%±5.4% 42.6%±9.2% 
LC stress fluox amph 4 43.2%±5%+ 45.9%±5% 55.3%6.4%++ 
Fluoxetine significantly increased FM call percentage in LC-stress amphetamine group on 
days 1 (p<.05) and 19 (p<.01), while the effect was not apparent on day 10. Interestingly, 
repeated treatment with amphetamine decreased FM call proportions in vehicle-treated HC 
non-stressed rats on days 1 and 10 (p<.05). The same effect was apparent among fluoxetine-
treated HC non-stressed group and in vehicle-treated LC non-stressed rats on day 10 (p<.05). 
However, a single dose of amphetamine increased frequency-modulated call proportions in 
HC and LC non-stressed rats, who had been previously treated with saline, on day 19 (p<.01). 
No sensitization effect can be concluded amid any group, since there were no significant 
differences in response to amphetamine in terms of FM call proportions. 
Flat calls during amphetamine administration 
Repeated measures ANOVA showed differences in number of flat calls across testing days 
[F(2,92)=60; p<.0001], whereas amphetamine significantly increased the flat call rate 
[F(1,46)=29.7; p<.0001]. Generally HC animals tended to emit higher number of flat calls 
than LC rats on all testing days [HC/LC x Amphetamine treatment - F(1,46)=8.5; p<.01]. 
(Figure 5) 
 
Figure 5. Mean scores of flat vocalizations scored from 7 selected time-bins on day 1, 10 and 19 (data expressed 
as mean + SEM). On day 19 all animals (n=62) were injected with amphetamine (1 mg/kg, IP) to examine the 
sensitization effect. *, **, *** - p<.05, .01, .001 vs day 1, respectively; &, &&, &&& - p<.05, .01, .001 vs 
saline, respectively; ¤, ¤¤, ¤¤¤ - p<.05, .01, .001 vs LC, respectively. 
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According to post-hoc tests, all HC groups showed increased flat call rate in response to 
amphetamine across all testing days (p<.05), although this effect was not significant among 
HC-stress fluoxetine-treated rats on day 10. Of note, there was a slight non-significant 
tendency for this effect among LC rats as well on day 10, but not on day 1 or 19. 
Repeated treatment with amphetamine provoked sensitization in flat calls across all HC 
groups, since the call rate on day 19 was significantly higher than the number of flat calls 
elicited on testing day 1 (p<.05), while remaining higher than the number of flat calls in their 
respective saline-groups on day 19 (p<.05). Interestingly, the effect could not be described 
among LC groups. Several LC groups had higher flat call rate than day 1, but a single dose of 
amphetamine on day 19 did not provoke statistically significant differences between 
previously saline and amphetamine treated rats. 
According to repeated measures ANOVA, the proportion of flat calls remained statistically 
the same across testing days, while the proportion depended on fluoxetine [interaction Day × 
Fluoxetine - F(2,92)=3.9; p<.05] and the interaction between HC/LC affiliation and CVS 
regimen [Day × HC/LC × Stress – F(2,92)=3.4; p<.05]. Proportion of flat calls within day 
depended on amphetamine treatment [F(1,46)=25.3; p<.0001] and fluoxetine [F(1,46)=4.8; 
p<.05], the latter having an interaction effect between [HC/LC × Stress × Fluoxetine – 
F(1,46)=6.1; p<.05]. Interestingly repeated treatment with amphetamine seemed to increase 
flat call proportions, while fluoxetine attenuated this effect among LC rats. Moreover HC rats 
tended to have higher flat call rate than LC rats in these conditions. On the other hand, 
vehicle-treated stressed LC rats showed higher flat call percentage than respective HC 
animals. 
Table 4. Flat call percentage from the overall number of USV-s elicited on day 1, 10 and 19. *, **, *** - p<.05, 
.01, .001 vs day 1, respectively; &, &&, &&& - p<.05, .01, .001 vs saline, respectively; ¤, ¤¤, ¤¤¤ - p<.05, .01, 
.001 vs LC, respectively. 
HC/LC CVS regimen FLUOX/SAL AMPH/SAL GROUP SIZE DAY 1 DAY 10 DAY 19 
HC ctrl veh sal 4 20.3%±5.4%¤ 19.5%±6.2% 18.6%±4.7% 
HC ctrl veh amph 4 55.7%±9.1%&&& 55%±6%&&& 50%±11%&& 
HC ctrl fluox sal 4 6.6%±4.5% 19.8%±6.7% 20.8%±4.5% 
HC ctrl fluox amph 4 35.8%±5.7%&& 48.8%±6.3%&& 43.3%±7.5%& 
HC stress veh sal 4 32.5%±3.2% 27.5%±4.7% 26.8%±1.7% 
HC stress veh amph 4 39.1%±6.8% 32%±8.8%&#¤ 32.5%±10.2%¤ 
HC stress fluox sal 4 24.2%±7.9% 32.2%±6.3% 29.3%±4.1% 
HC stress fluox amph 4 41.9%±5.6% 45.9%±10.1% 37.9%±1.6% 
LC ctrl veh sal 4 42.4%±5% 26.7%±3.2%* 25.4%±5.4%* 
LC ctrl veh amph 4 49.3%±4.9% 51.7%±8.1% 36.1%±8.2% 
LC ctrl fluox sal 4 26.6%±12.5% 37.4%±8.3% 32.5%±8% 
LC ctrl fluox amph 4 42.5%±14.8% 48.2%±7.8% 33.5%±4% 
LC stress veh sal 3 37.6%±10.8% 41.2%±16.5% 43.1%±10.6% 
LC stress veh amph 3 52.7%±6.5% 59.6%±3.2% 57.9%±3.1% 
LC stress fluox sal 4 16.8%±9.8% 26.2%±7.9% 35.7%±12.1%* 
LC stress fluox amph 4 31.1%±7.3% 30.1%±5.7%++ 26.1%±5%++ 
Amphetamine treatment seemed to increase flat call rate in proportion of overall USV activity 
in HC-control rats (p<.05). Effect was also apparent on testing day 10 among HC-stress 
vehicle animals (p<.05). Fluoxetine treatment decreased flat calls in proportion within LC-
stress amphetamine group on days 10 and 19 (p<.01). On days 10 and 19 HC-stress vehicle 
rats who had been repeatedly treated with amphetamine shower a lower proportion of flat call 
in contrast with their respective LC group (p<.05). The same effect appears to be the baseline 
difference between HC and LC subjects on day 1 (p<.05), since the HC non-stressed vehicle 
saline-treated animals had a lower flat call rate in proportions on day 1 than their respective 
LC group. The effect was not significant on days 10 and 19. 
 
Short calls during amphetamine administration 
Four-factor repeated measures ANOVA displayed differences in number of short calls across 
testing days [F(2,92)=27.6; p<.0001], depending on the subjects’ response to amphetamine 
[Day × Amphetamine - F(2,92)=20.3; p<.0001] (Figure 6). On days 1 and 10, amphetamine 
[F(1,46)=6.6; p<.01] tended to increase the number of short calls emitted among HC rats, but 
not on day 19. Furthermore, HC groups showed a higher number of short calls in response to 
amphetamine, than LC rats on these days [HC/LC - F(1,46)=13.5; p<.001], while this effect 
did not occur on day 19. 
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Figure 6. Mean scores of short vocalizations scored from 7 selected time-bins on day 1, 10 and 19 (data 
expressed as mean + SEM). On day 19 all animals (n=62) were injected with amphetamine (1 mg/kg, IP) to 
examine the sensitization effect. *, **, *** - p<.05, .01, .001 vs day 1, respectively; #, ##, ### - p<.05, .01 vs 
control, respectively; +, ++, +++ - p<.05, .01, .001 vs vehicle, respectively; &, &&, &&& - p<.05, .01, .001 vs 
saline, respectively; ¤, ¤¤, ¤¤¤ - p<.05, .01, .001 vs LC, respectively. 
There was an increase in short call numbers across all HC groups (p<.05), but not among LC 
animals on day 1. The only exception was fluoxetine-treated stressed rats (p<.01). 
Furthermore, there were baseline differences between HC and LC rats in response to acute 
amphetamine administration on day 1, since the HC non-stressed vehicle-treated group had 
higher number of short calls than contrasting LC rats (p<.05). However on day 10, all groups 
showed a tendency for increased short call numbers in response to repeated amphetamine 
administration, although this effect was significant only among HC-stressed rats (p<.05) and 
LC-stress fluoxetine treated group (p<.01). 
On day 19, when all animals received a single dose of amphetamine, vehicle-treated HC and 
non-stressed LC animals, showed a significantly higher number of short calls than their 
respective amphetamine-treated animals (p<.05). On the other hand, their contrasting stress-
groups had no such effect, provoking a significant stress effect (p<.05). No groups showed 
indications of sensitization on day 19, since the single dose of amphetamine did not provoke 
any differences in respective amphetamine and saline groups. 
Proportion of short calls differed across testing days [F(2,92)=19.1; p<.0001], depending on 
interaction between HC/LC affiliation, fluoxetine and amphetamine treatment [Day × HC/LC 
× Fluoxetine × Amphetamine – F(2,92)=4; p<.05]. Generally amphetamine-treated rats 
showed lower percentage of short calls, while the effect was most noticeable among LC 
animals. Moreover fluoxetine significantly increased saline-treated LC rats’ short call rate on 
day 1, but not on day 10 and 19. Amphetamine treatment had a main effect on proportion of 
short calls within testing day [F(1,46)=13.7; p<.001]. 
Table 5. Short call percentage from the overall number of USV-s elicited on day 1, 10 and 19. *, **, *** - 
p<.05, .01, .001 vs day 1, respectively; #, ##, ### - p<.05, .01 vs control, respectively; +, ++, +++ - p<.05, .01, 
.001 vs vehicle, respectively; &, &&, &&& - p<.05, .01, .001 vs saline, respectively; ¤, ¤¤, ¤¤¤ - p<.05, .01, 
.001 vs LC, respectively. 
HC/LC CVS regimen FLUOX/SAL AMPH/SAL GROUP SIZE DAY 1 DAY 10 DAY 19 
HC ctrl veh sal 4 28.3%±3.5% 25.4%±2.6% 19.9%±4.8% 
HC ctrl veh amph 4 19.8%±3.4% 16%±2.5% 10.6%±0.9% 
HC ctrl fluox sal 4 17.5%±10.2%¤¤¤ 12.4%±4.1% 16.7%±3.6% 
HC ctrl fluox amph 4 22.1%±0.9% 22.9%±3.1% 10.6%±1.1% 
HC stress veh sal 4 32.8%±2.9% 21.8%±4.2% 17.3%±2.6%* 
HC stress veh amph 4 21.5%±1.8% 18.2%±3.2% 12.1%±3.3% 
HC stress fluox sal 4 29.7%±4.2%¤¤ 28.7%±4.3% 25.3%±4.1% 
HC stress fluox amph 4 22.6%±2.5% 12.4%±1.5% 10.5%±2.1% 
LC ctrl veh sal 4 20.2%±2.2% 21%±2.0% 18.1%±3.7% 
LC ctrl veh amph 4 27.6%±9.7% 20.6%±7.8% 17.5%±6.4% 
LC ctrl fluox sal 4 45%±18.4%++ 16.2%±2.5%*** 13.7%±1.1%*** 
LC ctrl fluox amph 4 15.4%±3.2%&&& 20.3%±4.3% 8.5%±1.3% 
LC stress veh sal 3 29.2%±8.2% 24.1%±5.2% 19.4%±6.5% 
LC stress veh amph 3 23.9%±5.3% 13%±2.3% 11.7%±2.6% 
LC stress fluox sal 4 53.9%±21.2%++ 33.9%±8.2%**# 18.3%±3.7%*** 
LC stress fluox amph 4 24.6%±3.6%&&& 21.6%±4.5% 10.7%±1.9% 
On day 1, amphetamine decreased short call proportions among fluoxetine-treated LC rats, 
compared to their respective saline-treated groups (p<.001). Moreover, fluoxetine increased 
short call percentage among saline-treated LC animals (p<.01), while remaining significantly 
higher when compared to their respective HC groups (p<.001). Interestingly, these effects did 
not occur on day 10, or day 19 on a single dose of amphetamine. In fact, fluoxetine-treated 
LC groups showed significantly lower proportions of short calls on day 19, compared to their 
scores on day 1 (p<.001). 
Locomotor activity on day 19 
Four-factor ANOVA did not display any statistically significant factors on line crossings or 
rearings on day 19. There was a strong correlation between line crossings and rearings 
(r=.641; p<.001). In addition these variables correlated to USV activity differently; line 
crossings had a correlation of r=.332 (p<.01) and rearings r=.421 (p<.001). Furthermore, if 
summed into single variable, it presented a moderate correlation with overall number of USV-
s (r=.41; p<.001). On the other hand USV subtypes appeared to correlate differently with line 
crossings and rearings. Trill calls correlated with line crossing and rearings (r=.340 and .346 
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respectively, both – p<.01). FM-s correlated with line crossings and rearings (r=.307 and .341 
respectively, both – p<.01). Flat calls correlated only with rearings (r=.278; p<.05). Short 
calls had a significant correlation only with rearings (r=.330; p<.01). 
 
DISCUSSION 
The present study aimed to examine the effect of antidepressant treatment on amphetamine-
induced 50-kHz ultrasonic vocalizations in chronically stressed HC vs LC rats. The chronic 
variable stress regimen decreased weight gain, although the stress-induced attenuation of 
weight gain did not differ between HC and LC animals. These results are in accordance with 
previous works of our group (Mällo et al 2009; Raudkivi et al 2012). Somewhat unexpectedly 
fluoxetine treatment attenuated weight gain, compared to vehicle-treated rats. The effect of 
fluoxetine on weight gain may be related to group housing used during concordant CVS 
regimen and fluoxetine treatment. At observational level an increase of in-cage fighting was 
noted in animals after daily fluoxetine treatment, especially so in first weeks of fluoxetine 
treatment. Those results are corroborated by findings presented in meta-analysis by Carrillo 
and colleagues (2009), which indicate that increased serotonergic activity in Wistar rats, 
especially in context of stress-induced aggression, and treatment periods of less than 3 weeks 
has paradoxical aggression enhancing effect. The increase in aggression towards conspecifics 
might have decreased food intake, as it has been previously displayed with social defeat stress 
model (Meerlo, Overkamp, Daan, van den Hoofdakker, Koolhaas 1996). 
Previous chronic stress exposure facilitated the development of sensitization of USV response 
to subsequent repeated amphetamine treatment, as sensitization appeared only in previously 
chronically stressed animals. Both stressed and amphetamine treated groups of HC rats 
developed USV sensitization, whereas stressed LC rats showed USV sensitization only with 
fluoxetine pretreatment. These results resemble the phenomenon of cross-sensitization, where 
prior acute or chronic stress exposure increases the subsequent responsiveness to the effects of 
psychostimulant drugs (Cruz, Marin, Leão, Planeta 2012, Marinelli & Piazza 2002). Brain 
regions responsible for initiation and development of cross-sensitization are A9 dopaminergic 
neurons located in ventral tegmental area, projecting to nucleus accumbens (NAcc) (Kalivas 
& Stewart 1991). These structures are affected directly and/or indirectly by exposure to stress 
and amphetamine administration (Saal, Dong, Bonci, and Malenka 2003), and thus could 
explain the prevalence of cross-sensitization in the present study as well, although further 
work is necessary, to model the cross-sensitization effect on rat USV-s. Of note, to my 
knowledge, this study is the first to describe cross-sensitization in the context of drug induced 
USV activity as all previous relevant studies have used measures of locomotor activity.   
These results also suggest that fluoxetine pretreatment modulates the effect of chronic stress 
on amphetamine-induced USV-s. This was observed in stressed LC rats that did not develop 
sensitization unless having previously received fluoxetine. This effect of fluoxetine treatment 
could be associated with the functional level of the mesolimbic dopamine system, since it has 
been demonstrated that dopamine D1 and D2 receptors in nucleus accumbens shell are the key 
neural substrate in production of USV-s of all subtypes (Thompson, Leonard, and Brudzynski 
2006), while antidepressants of all classes increase the responsiveness of D2 dopamine 
receptors in NAcc (Willner et al 2013). Studies in humans have found that administration of 
dopamine receptor antagonists during treatment with SSRI-s causes reinstatement of 
depressed mood (Willner, Hale, and Argyropoulos 2005). In animal studies, it has been 
demonstrated that exposure to chronic stress induces several neurochemical changes in 
mesolimbic brain (Chaudhury et al 2013), and we have recently reported that some of these 
changes are different in HC vs. LC rats (Kõiv et al 2016). Therefore fluoxetine treatment 
could modulate the chronic stress effect on mesolimbic brain differently, depending on inter-
individual differences in positive affectivity. However, it should be noted that the present 
study does not incorporate any neurochemical measurements. Thus, this hypothesis is highly 
speculative, and should be tested in future studies. 
We have recently reported that prior chronic stress exposure affects the USV response to 
subsequent repeated amphetamine treatment dependently on the trait of positive affectivity 
(Kõiv et al 2016). More specifically, CVS regimen attenuated the USV response to 
amphetamine treatment only in animals characterized by low level of positive affectivity. 
Results from the present study thus differ from this finding as no CVS-induced attenuation of 
USV response to repeated amphetamine treatment occurred. This may be related to 
differences in chronic stress regimen used – i.e. two phase chronic stress regimen used 
previously vs. overall longer stress regimen without intermittent stopping of stress regimen 
used in the present experiment. Exposure to chronic stress provokes allostatic changes in the 
brain, which are partially differentiated by the ontogeny, i.e. what stressors are presented and 
how often, and duration of stress (Herman 2013). This effect is mainly prevalent in 
hypothalamo-pituitary-adrenocortical (HPA) axis, and is regulated mainly by glucocorticoids 
(Harvey, Brand, Jeeva, and Stein 2006), although mesencephalic dopamine regulation is also 
27 
affected (Imperato, Angelucci, Casolini, Zocchi, and Puglisi-Allegra 1992). In terms of 
chronic stress effect on USV activity, the changes in mesolimbic dopamine pathway’s 
synaptic long-term potentiation is of most importance, since the effects of dopaminergic 
psychostimulants like d-amphetamine are directly affected by the latter mechanism (Saal et al 
2003). It is possible that this mechanism is differently altered by the CVS regimen in our two 
studies, which induces distinct changes in dopaminergic neurotransmission, and hence could 
modulate the USV response to amphetamine. 
Previous studies have often linked 50-kHz vocalizations to rewards, and these calls are 
thought to express approach behaviour in some conditions, i.e. social incentive stimuli, 
feeding, and anticipation of pharmacological rewards (Knutson et al 2002; Wöhr & 
Schwarting 2007; Browning et al 2011). It has been previously postulated that 50-kHz USV 
subcategories reflect different positive emotional and motivational states, indicated by the 
contextual differences between them (Brudzynski 2015). More importantly, sensitization in 
frequency-modulated and trill calls, but not in flat and short calls, has previously been 
observed across some studies with repeated amphetamine administration (Ahrens et al 2009; 
Rippberger, van Gaalen, Schwarting, Wöhr 2015). On the other hand, there have been reports, 
which describe decrease or no change in FM and trill calls (for review, see Simola 2015). 
These differences may occur due to data recording during different stages of reward 
anticipation and acquisition. Opiol and colleagues (2015) have demonstrated that FM calls are 
exhibited mostly during anticipation stages of food reward, while flat calls seem to be 
noticeably associated with acquisition of food and social signaling of the latter. These 
findings could apply to pharmacological rewards as well, although further research is required 
for more specific conclusions. 
In the present study, the sensitization of trill and FM calls was noticeable in call proportions 
in fluoxetine-treated stressed LC animals, which received repeated treatment with 
amphetamine, but not in any other group: fluoxetine pretreatment increased the frequency-
modulated and trill calls in proportions, and decreased the percentage of flat calls during 
amphetamine administration. Previous work has suggested that frequency-modulated calls, 
especially vocalizations with trill-elements, reflect highly rewarding and motivated affective 
states, and are mostly emitted in response to psychostimulant treatment (Brudzynski 2015; 
Burgdorf, Panksepp, Moskal 2011). The findings in the present study support this hypothesis 
to some extent; however, it is important to note that these results were reflected in 
proportions, not in overall number of call subtypes.  
The increase in the mean number of frequency-modulated calls emitted after repeated 
administration of amphetamine was noticeable in stressed HC rats, while significant only in 
the fluoxetine-pretreated group at the sensitization testing. Interestingly there were no changes 
in proportions of FM calls across testing days in this group, while there was a tendency for 
increased proportion of flat calls. In fact there was a substantial increase of flat call rate 
among all HC groups in response to repeated treatment with amphetamine. It has been 
previously postulated that flat calls serve as contact signals and are not necessarily emitted in 
rewarding situations (Wöhr et al 2008; Burgdorf et al 2008). The present findings suggest that 
flat calls do reflect some kind of positive affective state in response to repeated 
psychostimulant treatment, although it may not be similar to the state which is expressed with 
FM and trill calls.  
Repeated treatment with amphetamine did not significantly increase locomotor activity in any 
group at the sensitization testing. These results suggest that sensitization in USV-s is not 
necessarily accompanied with increase in locomotor activity, which is in accordance with 
previous findings, indicating that fifty-kHz USV-s are independent from locomotor activity 
(Knutson, Burgdorf, Panksepp 2002). Nonetheless this study presents a significant correlation 
between USV and locomotor activity, while demonstrating some interesting differences 
between subtypes of 50-kHz vocalizations and indicators of locomotor activity. These 
correlations were moderate, but unlikely to be random, since we demonstrated similar results 
in our previous experiment (Kõiv et al 2016). The more detailed understanding of 
associations between locomotor activity and ultrasonic vocalizations should be addressed in 
future studies. 
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CONCLUSIONS 
This study provides new insights into antidepressant action on positive affect regulation and 
how chronic stress modulates the development of drug abuse. The main conclusions in the 
current study were: 
 fluoxetine, while in interaction with chronic stress, has a different effect on amphetamine-
induced ultrasonic vocalization activity among animals with high vs. low baseline level of 
positive affectivity, since chronically stressed LC rats did not develop sensitization unless 
having previously received fluoxetine, whereas sensitization occurred in both stressed HC 
groups repeatedly treated with amphetamine; 
 rats with lower baseline levels of positive affectivity showed increased proportions of 
frequency-modulated and trill calls in response to repeated treatment with amphetamine, 
while respective HC rats did not, which suggests that HC vs. LC rats might have 
experienced different positive affective state in response to amphetamine; 
 rats with higher positive affectivity showed increased flat call rate in response to 
amphetamine treatment, which suggests that flat calls do have an association with positive 
affective stimuli. 
The present experiment had a group size of 3-4 rats, which is a clear limitation in 
interpretation of aforementioned results due to large individual variability in vocalization 
activity. In addition the animals used in experiments were group-housed, and any 
environmental differences with single-housing cannot be excluded. Hence it would be wise to 
draw conclusions with some precaution.  
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